These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11277523)

  • 1. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.
    Springer DM; Luh BY; Goodrich JT; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):281-91. PubMed ID: 12470721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives.
    Springer DM; Luh BY; Goodrich J; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):265-79. PubMed ID: 12470720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
    Glinka TW; Cho A; Zhang ZJ; Ludwikow M; Griffith D; Huie K; Hecker SJ; Dudley MN; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1045-52. PubMed ID: 11132949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
    Cho A; Glinka TW; Ludwikow M; Fan AT; Wang M; Hecker SJ
    Bioorg Med Chem Lett; 2001 Jan; 11(2):137-40. PubMed ID: 11206444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
    Masakitsushima ; Iwamatsu K; Umemura E; Kudo T; Sato Y; Shiokawa S; Takizawa H; Kano Y; Kobayashi K; Ida T; Tamura A; Atsumi K
    Bioorg Med Chem; 2000 Dec; 8(12):2781-9. PubMed ID: 11131169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
    J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Kamiyama K; Matsunaga N; Tawada H; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1071-85. PubMed ID: 11132951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
    Pohlmann J; Vasilevich NI; Glushkov AI; Kellenberger L; Shapiro S; Caspers P; Page MG; Danel F
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4635-8. PubMed ID: 20576430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3.
    Ishikawa T; Kamiyama K; Nakayama Y; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Mar; 54(3):257-77. PubMed ID: 11372783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel cephalosporin derivatives possessing a substituted cinnamoyl moiety at the 7 beta-position. Synthesis, structural characterization and antibacterial activity of 3-acetoxymethyl cephalosporin derivatives.
    López MA; Rodríguez Z; González M; Tolón B; Avila R; González I; Garmendía L; Mamposo T; Carrasco R; Pellón R; Vélez H; Fini A
    Eur J Med Chem; 2004 Aug; 39(8):657-64. PubMed ID: 15276299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546).
    Glinka T; Huie K; Cho A; Ludwikow M; Blais J; Griffith D; Hecker S; Dudley M
    Bioorg Med Chem; 2003 Feb; 11(4):591-600. PubMed ID: 12538024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.